Moderna Releases Data on mRNA Vaccine for 3 Respiratory Viruses
Vaccines
Jennifer Beam Dowd, PhD
Good news image released today by Moderna, showing positive pre-clinical data (IN MICE!) for an mRNA vaccine that combines mRNA for 3 different respiratory viruses in 1 vaccine: COVID-19 + Flu + RSV. One silver lining of this terrible pandemic might be a huge leap forward in our scientific knowledge and specifically vaccine technology… let’s Read more…
September 9, 2021
What’s up with monoclonal antibodies for COVID-19 infections?
Treatments
Sarah Whitley Coles, MD
The safety profile for monoclonal antibody treatment is very good. For people with COVID-19 infections who do not need to be hospitalized and who are at high risk of progressing to severe illness, monoclonal antibody therapies can reduce the risk of hospitalization and death. Monoclonal antibody therapies use laboratory made antibodies that are Read more…
Good news image released today by Moderna, showing positive pre-clinical data (IN MICE!) for an mRNA vaccine that combines mRNA for 3 different respiratory viruses in 1 vaccine: COVID-19 + Flu + RSV. One silver lining of this terrible pandemic might be a huge leap forward in our scientific knowledge and specifically vaccine technology… let’s Read more…
What’s up with monoclonal antibodies for COVID-19 infections?
Treatments
Sarah Whitley Coles, MD
The safety profile for monoclonal antibody treatment is very good. For people with COVID-19 infections who do not need to be hospitalized and who are at high risk of progressing to severe illness, monoclonal antibody therapies can reduce the risk of hospitalization and death. Monoclonal antibody therapies use laboratory made antibodies that are Read more…
The safety profile for monoclonal antibody treatment is very good. For people with COVID-19 infections who do not need to be hospitalized and who are at high risk of progressing to severe illness, monoclonal antibody therapies can reduce the risk of hospitalization and death. Monoclonal antibody therapies use laboratory made antibodies that are Read more…
Get a discounted subscriber rate until Sept 11
Please become a Paid Subscriber to our twice-weekly Substack email newsletter. Enjoy a 10% discount on the $50 yearly rate until September 11, 2026.
Be part of the movement to ensure Those Nerdy Girls can continue to be a trusted messenger of health information for all. We need you in order to sustain the work.
